Table 3.
Multivariate Regression for Presence of Mid-Wall Fibrosis
3A. Imaging | |||
(Model χ2 = 11.8, p = 0.008) | |||
Variable (CMR) | Odds Ratio | 95% Confidence Interval | P |
LV End-Diastolic Volume (per 10 ml/m2) | 1.14 | 1.02–1.29 | 0.03 |
LV Ejection Fraction (per 10 % decrement) | 0.84 | 0.50–1.42 | 0.51 |
Myocardial Mass (per 10 g/m2) | 0.99 | 0.84–1.17 | 0.90 |
3B. Clinical | |||
(Model χ2 = 48.0, p < 0.001) | |||
Variable | Odds Ratio | 95% Confidence Interval | P |
Non-Ischemic Etiology | 17.80 | 6.3– 50.3 | <0.001 |
Hypertension | 0.95 | 0.41 – 2.21 | 0.91 |
Age (years) | 1.00 | 0.97 – 1.03 | 0.93 |
3C. Integrated Clinical/Imaging | |||
(Model χ2 = 52.5, p < 0.001) | |||
Variable | Odds Ratio | 95% Confidence Interval | P |
Non-Ischemic Etiology | 15.99 | 5.80– 44.13 | <0.001 |
LV End-Diastolic Volume (10 ml/m2) | 1.13 | 1.004 – 1.27 | 0.04 |
LV Ejection Fraction (per 10 % decrement) | 1.17 | 0.68 – 2.02 | 0.57 |